- Reuters•8 months ago
The antitrust division of the U.S. Department of Justice has subpoenaed Mylan N.V. for information relating to the pricing and marketing of its generic doxycycline antibiotic products, the drugmaker said on Friday. The Department of Justice has also sought information on any communication with competitors about the anti-bacterial products, the company said in a regulatory filing, adding it would cooperate with the federal agency. Competitors Endo International and Allergan Inc have also received similar subpoenas, according to regulatory filings made by them in November and August.
We're sorry this is all we were able to find about this topic.
Sun Pharma Advanced Research Company LimitedNSE
|52wk Range||243.54 - 441.64|
|Day's Range||356.45 - 375.45|
|Avg Vol (3m)||372,778|
As of 5:59 AM EDT. Market closed.